Share Consolidation

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

(TheNewswire)

Lexston Life Sciences Corp.

Vancouver, British Columbia – TheNewswire - May 20, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) is providing the following update regarding its common share consolidation announced on May 13, 2022.

The common shares of the Company will be consolidated on the ratio of five (5) pre-consolidated shares for one (1) post-consolidated share.  Each fractional share remaining after the consolidation that is less than 1/2 of a share will be cancelled and each fractional share that is at least 1/2 of a share will be changed to one whole share.

The Company set May 27, 2022 as the record date for the consolidation of its common shares.  Trading on a consolidated basis will start on May 26, 2022.

As a result, the outstanding common shares of the Company will be reduced to approximately 11,746,727 common shares.

The name and the stock symbol of the Company will not change.

The new ISIN of the Company is CA52978A2056 and the new  CUSIP is 52978A205.

Letters of transmittal will be mailed to the shareholders of the Company.

On Behalf of the Board of Directors

LEXSTON LIFE SCIENCES CORP.

Jagdip Bal Chief Executive Officer

Telephone: (604) 928-8913

Copyright (c) 2022 TheNewswire - All rights reserved.